-
Healthy corals help bleached neighbors regain color: study
-
Indonesia rescues starved orangutan from fires: officials
-
Hope ton helps West Indies level T20 series at 2-2 in India
-
Real Madrid's Vinicius banned for Clasico after red card
-
Ukraine war reaches shores of Bulgarian fishing village
-
Restrictions expose Ukraine's Starlink dependency in Russia war: observers
-
Brazil probing 'criminal' origin of forest fires: minister to AFP
-
Espada out as Astros manager while Mattingly stays with Phillies
-
Sally Rooney books cannot be sold in UK amid Palestine Action ban: publisher
-
Houthis say targeted Saudi oil giant Aramco, vow more attacks
-
Italian ski stars Goggia and Brignone to miss season opener
-
Govt takes control of Turkey's most-watched news channel
-
Bournemouth boss Rose urges Cherries to bounce back from Chelsea 'slap'
-
FIFA to offer members $6.35-billion development fund windfall
-
Top seed Sabalenka falls at first hurdle in Wuhan
-
US consumer inflation hotter than expected as midterms loom
-
FX Junction Brings Copy Trading to Everyone, While Their Money Never Leaves With Their Broker
-
INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer’s Drug Research and Explore New Applications for XPro
-
Brighton defender Struijk's red card overturned
-
Hot US inflation data dents Wall Street stocks
-
Saudi league postpones three matches after Houthi attacks
-
India sends 'cockroach' leaders to jail after protest
-
US consumer inflation up more than expected as midterms loom
-
'Sinners' director Ryan Coogler to reboot 'X-Files' for Disney
-
Canadian publisher supports novelist Orelien after AI denial
-
Lufthansa wins contest for TAP Air Portugal stake
-
Medvedev sees off Tsitsipas to reach Shanghai Masters quarters
-
AI worms, 'major' incident fears spur safety calls at industry summit
-
Louvre boss warns of closure risk without major renovations
-
Fuel shortage triggers queues on Indonesia's Bali island
-
Lawes and Genge urge England to end ban on overseas-based players
-
Evolution Metals & Technologies Corp. Reaffirms $400 Million to $460 Million FY2027 Revenue Guidance, Unveils Eight Sintered Magnet Grades Covering an Estimated 75% of Global NdFeB Revenue, and Moves to Answer U.S. Army Call for Rare Earth Magnets
-
Metrika Selected by OCC to Support Stablecoin Supervisory Framework Under the GENIUS Act
-
Trial defence says Russia used Nord Stream pipelines as 'weapon'
-
Kenya hosting 2029 World Championships will help doping fight, says Coe
-
Israeli settlers set fire to mosque in occupied West Bank
-
UK prosecutor tells jury Russell Brand a 'sexual predator'
-
Macron says French student protesters 'exploited' by political forces: spokeswoman
-
Fulham manager Arbeloa fined £25,000 after Man Utd outburst
-
Stocks diverge ahead of key US inflation data
-
Nepal flood triggered by rock and ice avalanche: report
-
Japan summons Russian ambassador to protest journalist's arrest
-
'Distressed' family of UK man killed by tiger urge end to online posts
-
Workers to strike at world's largest copper mine in Chile
-
Regulator expects Man City appeal to be heard by January
-
Ukraine accuses US of helping Russia as missiles hit Kyiv
-
Rising Spanish tennis star handed code violation for swearing at ballboy
-
Drone hits data centre of Russia's largest bank
-
Last of the French musketeers Monfils officially retired from tennis
-
Bivial AG Brings Its Complete Dashboard to Mobile
Apple to appeal US Watch ban
Apple said on Tuesday it will appeal a US import ban on its latest smartwatch models after the Biden administration opted to not veto a ruling on patent infringements.
The ban on Apple's latest smartwatch models came into effect Tuesday, with the Apple Watch Series 9 and Apple Watch Ultra 2 no longer available in stores or online.
The ban is the latest legal tussle involving big tech companies over valuable patents that has also seen Google battle in court against Sonos in a fight over speaker tech.
The United States International Trade Commission (ITC) decided in October to ban the Apple Watch models over a patented technology for detecting blood-oxygen levels.
The order stemmed from a complaint made to the commission in mid-2021 by Masimo Corp, in which the medical device maker accused Apple of infringing on "light-based oximetry functionality."
"After careful consultations, Ambassador (Katherine) Tai decided not to reverse the... determination and the ITC's decision became final on December 26, 2023," the office of the US Trade Representative said in a statement on Tuesday.
Though the US president's office has authority to reverse import bans, such actions are only taken rarely.
In a statement, Masimo said the confirmed ban "is a win for the integrity of the US patent system, and ultimately American consumers who will benefit from an ecosystem that rewards true innovation."
Apple contends that the ITC finding was in error and should be reversed, filing an appeal in a US federal court.
But the company pulled the products from the online Apple Store on December 21, with retail locations ceasing sales December 24 — just ahead of the holiday.
Masimo contends it invented the technology — and that Apple poached its employees to win access to the knowledge.
- 'Strongly disagree' -
Apple has been steadily ramping up fitness and health features with each generation of its Apple Watch, which dominates the smartwatch category.
In September, Apple released the Apple Watch Series 9, touting increased performance along with features such as the ability to access and log health data.
"We strongly disagree with the USITC decision and resulting exclusion order, and are taking all measures to return Apple Watch Series 9 and Apple Watch Ultra 2 to customers in the US as soon as possible," Apple said in a statement Tuesday.
At the time of the original decision, Apple said Masimo had "wrongly attempted to use the ITC to keep a potentially lifesaving product from millions of US consumers while making way for their own watch that copies Apple."
In May, a trial of Masimo's allegations ended in a mistrial after jurors failed to reach a unanimous verdict.
Apple has argued that Masimo is using litigation to make way for its own Apple Watch-inspired products.
In November, Masimo was cleared by US regulators to use its own wrist-worn product for prescription and over-the-counter use.
Late last year, Apple filed two patent infringement lawsuits accusing Masimo of copying Apple Watch technology.
M.Furrer--BTB